Transverse Myelitis
Clinical guidelines for managing acute spinal cord inflammation, immunotherapies, and long-term functional recovery.
Table of Contents
π§ Standard of Care & Symptoms
Transverse Myelitis (TM) is a neurological disorder caused by inflammation across both sides of one segment of the spinal cord. The inflammation damages myelin (the protective covering of nerve fibers), disrupting the electrical signals that the spinal cord sends throughout the body.
- Presentation: Symptoms typically develop rapidly over hours to days. Key signs include localized back pain, band-like tightness around the torso, sudden leg/arm weakness, sensory loss (numbness or tingling), and bowel/bladder dysfunction.
- Causes: Can be idiopathic (no cause found), but is often triggered by viral/bacterial infections, autoimmune disorders (like Lupus or Sjogren's), or represent the first attack of a demyelinating disease like Multiple Sclerosis or Neuromyelitis Optica.
- Diagnosis: Confirmed via spine MRI (showing spinal cord swelling and inflammation) and lumbar puncture (showing elevated protein and white blood cells in cerebrospinal fluid).
π Acute Immunotherapies
Acute management aims to suppress spinal cord inflammation immediately to prevent permanent spinal cord injury and paralysis.
High-Dose Intravenous Corticosteroids
The first-line therapy for acute TM. Patients are given high-dose Methylprednisolone (1,000 mg IV daily) for 3 to 5 consecutive days to rapidly reduce swelling around the spinal cord.
Plasma Exchange (PLEX)
Recommended for patients who do not show clinical improvement after 3 days of steroid therapy. PLEX filters antibodies and inflammatory proteins from the bloodstream and is highly effective at rescuing motor function when initiated early.
Intravenous Immunoglobulin (IVIG)
In cases where PLEX is unavailable or contraindicated, IVIG is used to neutralize overactive immune cells and protect myelin from further attack.
β‘ Rehabilitation & Recovery
Once the acute inflammation has resolved, rehabilitation is critical to restore muscle strength and manage complications.
- Physical Therapy: Focuses on rebuilding leg and arm strength, improving walking coordination, and maintaining joint flexibility to prevent contractures.
- Occupational Therapy: Teaches patients new ways to perform activities of daily living (such as bathing, dressing, or grooming) using adaptive equipment.
- Symptom Management: Medications like Baclofen or Gabapentin are used to treat painful muscle spasms and neuropathic pain that often persist after spinal cord injury.
π¬ Active Clinical Trials
Research evaluates early-stage rescue protocols, long-term functional recovery, and novel neuroprotective agents.
- NCT06992199: Evaluating functional outcome improvements of starting plasma exchange (PLEX) within 48 hours of steroid-refractory transverse myelitis.
- NCT07018299: Comparing 12-month mobility and independence outcomes between intense inpatient neuro-rehabilitation vs standard outpatient therapy.
- NCT07119255: A safety study evaluating a novel neuroprotective compound administered during acute myelitis to prevent nerve fiber damage.
πΊοΈ Next Steps After Diagnosis
If you or a loved one has recently been diagnosed with Transverse Myelitis, take these active steps to support functional recovery:
- Seek Immediate Specialized Neurology Care: Ensure you are managed by a neurologist specializing in neuro-immunology to rule out systemic triggers (like Lupus or MS) and define long-term preventative therapies.
- Initiate Early Physical Therapy: Begin gentle physical therapy as soon as your acute physician approves. Early mobilization helps maintain joint flexibility, prevents muscle atrophy, and trains secondary nerve pathways.
- Monitor Bowel and Bladder Function: Spinal cord inflammation commonly disrupts bladder and bowel signaling. Work with a urologist to manage urinary retention or incontinence using appropriate protocols.
- Manage Neuropathic Complications: Discuss pharmacological options (such as Gabapentin or Baclofen) with your doctor to control painful burning sensations, spasms, or muscle stiffness.
β Patient FAQ
Q: What is the recovery rate for Transverse Myelitis?
A: Recovery generally begins within 2 to 12 weeks of the attack and can continue for up to two years. Roughly one-third of patients experience complete recovery, one-third are left with moderate disability (spasms or bladder issues), and one-third experience permanent severe disability requiring a wheelchair.
Q: Is Transverse Myelitis the same as Multiple Sclerosis?
A: No. Transverse myelitis refers to a single episode of inflammation across the spinal cord. While a person with MS can experience transverse myelitis as a symptom, MS is characterized by multiple inflammatory episodes in the brain and spinal cord over time.
Get the Free 2026 Clinical AI Directory
Email us at caleb@openphr.org to receive our exclusive directory of over 150 open-source models and clinical trial databases.